相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting Peroxisome Proliferator-Activated Receptors (PPARs): Development of Modulators
Celine Pirat et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Design and Biological Evaluation of Novel, Balanced Dual PPARα/γ Agonists
Uwe Grether et al.
CHEMMEDCHEM (2009)
Efficient synthesis of 5-and 6-tributylstannylindoles and their reactivity with acid chlorides in the Stille coupling reaction
Khalil Cherry et al.
TETRAHEDRON LETTERS (2007)
The next generation of PPAR drugs: Do we have the tools to find them?
Barry G. Shearer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Design, synthesis, and structure -: activity relationship of carbamate-tethered aryl propanoic acids as novel PPARα/γ dual agonists
Nam-Jung Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-based design of indole propionic acids as novel PPARα/γ co-agonists
Bernd Kuhn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
PPARs: therapeutic targets for metabolic disease
JP Berger et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy
G Chinetti-Gbaguidi et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Bone is a target for the antidiabetic compound rosiglitazone
SO Rzonca et al.
ENDOCRINOLOGY (2004)
Novel tricyclic-α-alkyloxyphenylpropionic acids:: Dual PPARα/γ agonists with hypolipidemic and antidiabetic activity
P Sauerberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Binding of prostaglandins to human PPARγ:: tool assessment and new natural ligands
G Ferry et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight
E Chaput et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
